StrokeIschemic Attack, TransientBrain IschemiaCerebrovascular DisordersRisk FactorsAnticoagulantsWarfarinAtrial FibrillationFibrinolytic AgentsCerebral InfarctionCerebral HemorrhageProspective StudiesSecondary PreventionAspirinTreatment OutcomePlatelet Aggregation InhibitorsFollow-Up StudiesTime FactorsAcute DiseaseTissue Plasminogen ActivatorRecurrenceCarotid StenosisThrombolytic TherapyBrain InfarctionCohort StudiesIntracranial EmbolismEndarterectomy, Carotidbeta-AlanineIntracranial HemorrhagesTomography, X-Ray ComputedIncidenceInfarction, Middle Cerebral ArteryCarotid Artery DiseasesRandomized Controlled Trials as TopicRisk AssessmentIntracranial Arterial DiseasesCerebral AngiographyMagnetic Resonance ImagingEmbolismRetrospective StudiesBrainAge FactorsPredictive Value of TestsThromboembolismSeverity of Illness IndexCerebrovascular CirculationComorbidityRiskMagnetic Resonance AngiographyHypertensionAtrial AppendageNeurologyCase-Control StudiesIntracranial ArteriosclerosisPrognosisHemorrhageDipyridamoleIntracranial Embolism and ThrombosisRegistriesCarotid Artery, InternalPyridonesIschemiaPrimary PreventionOdds RatioRecovery of FunctionDiffusion Magnetic Resonance ImagingSex FactorsIntracranial ThrombosisForamen Ovale, PatentCerebral ArteriesPrevalenceAmaurosis FugaxUltrasonography, Doppler, TranscranialMultivariate AnalysisUnited StatesHeart DiseasesCarotid ArteriesLogistic ModelsBenzimidazolesMigraine DisordersDouble-Blind MethodTiclopidineNeurologic ExaminationMyocardial InfarctionProportional Hazards ModelsAustriaDiabetes ComplicationsClinical Trials as TopicCyclic Nucleotide Phosphodiesterases, Type 3Myocardial IschemiaMiddle Cerebral ArteryParesisPatient SelectionVertebrobasilar InsufficiencyInternational Normalized RatioBlood PressureArterial Occlusive DiseasesBiological MarkersDatabases, FactualEmergency Medical Services